Fresenius Medical Care

Forecast & Rating7 analysts currently cover Fresenius Medical Care, with about 28.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $25.68, about 0.1% downside from the current price of $25.70. Price targets range from $18.12 to $37.88 — a wide spread, showing clear disagreement over just how much Fresenius Medical Care can rise. Historically, about 52.2% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Fresenius Medical Care's outlook. Data as of Jul 30, 2026; for reference only and not investment advice.